Deep knowledge on 
 small-molecule drugs and 
 the 110,000 global patents 
 covering them 

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Drugs With the Most Patents

Number of drug patents per pharmaceutical drug

This chart shows the pharmaceutical drugs with the most patents still in force.

The number of patents covering a drug can be indicative of the value of a drug — more valuable drugs justify the substantial expense of building and maintaining large patent portfolios — but they can also be indicative of a company's legal or R&D acumen.

One clear way to keep competitors at bay is to surround key drugs with a web of strong patents, making it unlikely there will be any way to work around patents or invalidate a sufficient number of them. A large patent portfolio can also indicate strong, innovation-oriented R&D, with a focus on securing IP.

The drugs with the most unexpired patents are REVLIMID, AFREZZA, STIOLTO RESPIMAT, STRIVERDI RESPIMAT, VASCEPA, XIFAXAN, PROMACTA, BYDUREON, EVZIO, and KALETRA.

Back to Pharmaceutical Patent Infographics

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Copyright 2002-2016 thinkBiotech LLC
ISSN: 2162-2639

Connect with Social Media:

`abc